# A Study to Investigate Leramistat in Patients With IPF

> **NCT05951296** · PHASE2 · WITHDRAWN · sponsor: **Modern Biosciences Ltd**

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Leramistat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05951296
- **Lead sponsor:** Modern Biosciences Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-08-30
- **Primary completion:** 2024-02-27
- **Final completion:** 2024-03-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to slow initial recruitment and a lack of confidence in our ability to complete recruitment within the forecasted timeframe.
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05951296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05951296, "A Study to Investigate Leramistat in Patients With IPF". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05951296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*